Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Arcellx Inc | ACLX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 52.25 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 52.25 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 30.74 - 75.10 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 52.25 | USD |
Arcellx Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.76B | 52.80M | - | 110.32M | -70.69M | -1.34 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Arcellx News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACLX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 52.46 | 55.85 | 50.735 | 52.61 | 363,338 | -0.21 | -0.40% |
| 1 Month | 59.54 | 60.51 | 49.66 | 53.39 | 461,579 | -7.29 | -12.24% |
| 3 Months | 65.14 | 75.10 | 49.66 | 62.32 | 454,629 | -12.89 | -19.79% |
| 6 Months | 46.98 | 75.10 | 43.5029 | 57.42 | 549,554 | 5.27 | 11.22% |
| 1 Year | 43.66 | 75.10 | 30.74 | 46.94 | 547,609 | 8.59 | 19.67% |
| 3 Years | 19.00 | 75.10 | 6.035 | 36.01 | 480,001 | 33.25 | 175.00% |
| 5 Years | 19.00 | 75.10 | 6.035 | 36.01 | 480,001 | 33.25 | 175.00% |
Arcellx Description
| Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. |
